---
title: "002399.SZ (002399.SZ) — Related News"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/002399.SZ/news.md"
symbol: "002399.SZ"
name: "002399.SZ"
parent: "https://longbridge.com/en/quote/002399.SZ.md"
datetime: "2026-05-20T22:48:29.918Z"
locales:
  - [en](https://longbridge.com/en/quote/002399.SZ/news.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/002399.SZ/news.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/002399.SZ/news.md)
---

# 002399.SZ (002399.SZ) — Related News

### [Resverlogix Announces One-Year Extension of Debenture | RVXCF Stock News](https://longbridge.com/en/news/285999310.md)
*2026-05-11T13:15:00.000Z*
> Resverlogix Corp. has announced a one-year extension of its US$6.0 million secured debenture with Shenzhen Hepalink Phar

### [Hepalink's net profit attributable to the parent company in the first quarter was 188 million yuan, a year-on-year increase of 19.79%](https://longbridge.com/en/news/284537024.md)
*2026-04-29T09:43:03.000Z*
> Hepalink released its Q1 2026 performance, with operating revenue of 1.331 billion yuan, a year-on-year decrease of 4.55

### [In the first quarter, Hepalink's net profit rose by 19.8% to 190 million RMB](https://longbridge.com/en/news/284545136.md)
*2026-04-29T09:42:00.000Z*
> According to a report from Economic Information Daily on the 29th, Hepalink announced that its net profit for the first 

### [Hepalink's non-recurring net profit increased by over 60%, and its main business profitability has reached a new level](https://longbridge.com/en/news/281308164.md)
*2026-04-01T05:47:17.000Z*
> Hepalink / Released the 2025 annual performance report, with revenue of 5.479 billion yuan, a year-on-year increase of 3

### [Hepalink 2025 Annual Report Observation: Building Industrial Chain Competitiveness from Production Capacity to Platform](https://longbridge.com/en/news/281154058.md)
*2026-03-31T06:10:08.000Z*
> Hepalink's 2025 financial report shows that the global revenue from the enoxaparin sodium formulation business achieved 

### ["Performance" Hepalink's annual net profit of RMB 349 million fell by 46%, with a final dividend of 14.5 cents per share](https://longbridge.com/en/news/281104449.md)
*2026-03-31T01:27:58.000Z*
> HEPALINK announced its full-year results for the year ended December last year, with a revenue of RMB 5.438 billion, an 

### [List of performance of some listed companies (Fourteen)](https://longbridge.com/en/news/281155821.md)
*2026-03-31T00:30:00.000Z*
> "Economic News Agency, 31st Special Report" lists the performance of some listed companies: Stock Name Annual Period Net

### [<Hot Stocks> In February, Biostar's profits skyrocketed 89 times, earning more in a single month than the entire last year, with a weekly increase of over 40%](https://longbridge.com/en/news/280005292.md)
*2026-03-21T02:09:58.000Z*
> Biostar (2399-TW) saw a significant increase in profits in February, with a monthly net profit after tax reaching NT$ 14

### [Intraday News - Biostar (2399) surged 7.32%, reported at 24.2 yuan](https://longbridge.com/en/news/274582855.md)
*2026-02-03T01:42:43.000Z*
> Biostar (2399-TW) stock price rose by NT$1.65 at 09:42 on the 3rd, reaching NT$24.2, an increase of 7.32%, with a tradin